Is Amantadine Hydrochloride compatible with breastfeeding? Do we have alternatives for Amantadine Hydrochloride?

Amantadine Hydrochloride

February 1, 2017 (Low Risk)

Antiviral used for treatment and prophylaxis of type-A Influenza. Since it is a dopamine agonist is also used to treat Parkinson’s disease.

At latest update relevant published data on excretion into breast milk were not found.

Because of large volume of distribution and low plasma level observed (Pacifici 1976), a passage of significant amount through breastmilk or side-effects on the infant are not likely to occur.

Amantadine reduces plasma levels of prolactin, it has been used to treat galactorrhea caused by the use of dopaminergic neuroleptic drugs (Siever 1981 Correa 1987, Marken 1992, Carvalho 2011), however there is not information about the effect on lactating mothers. Prolactin is important to milk production especially during the first few weeks within birth. Frequent and effective stimulation of the nipple by the infant is essential on the maintenance of breastfeeding.

Whether administered during breastfeeding, it would be advisable not to use it in the neonatal period and monitor milk production.

Alternatives

Very Low Risk

Compatible. Not risky for breastfeeding or infant.

Low Risk

Moderately safe. Mild risk possible. Follow up recommended. Read the Comment.

High Risk

Poorly safe. Evaluate carefully. Use a safer alternative. Read the Comment.

Very High Risk

Not recommended. Cessation of breastfeeding or alternative.

Synonyms

  • 1-Aminoadamantane
  • Amantadine
  • Amantadine Sulfate

Writings

  • أمانتادين (Arabic)
  • Амантадин (Cyrillic)
  • 金刚烷胺 (Chinese)
  • アマンタジン (Japanese)
  • C10H17N (Molecular formula)

References

  1. Novartis. Amantadine. Data Sheet. 2011 Full text (in our servers)
  2. Carvalho MM, Góis C. [Hyperprolactinemia in mentally ill patients]. Acta Med Port. 2011Abstract
  3. AEMPS. Amantadina. Ficha técnica. 2010 Full text (in our servers)
  4. Marken PA, Haykal RF, Fisher JN. Management of psychotropic-induced hyperprolactinemia. Clin Pharm. 1992Abstract
  5. Correa N, Opler LA, Kay SR, Birmaher B. Amantadine in the treatment of neuroendocrine side effects of neuroleptics. J Clin Psychopharmacol. 1987Abstract
  6. Siever LJ. The effect of amantadine on prolactin levels and galactorrhea on neuroleptic-treated patients. J Clin Psychopharmacol. 1981Abstract
  7. Pacifici GM, Nardini M, Ferrari P, Latini R, Fieschi C, Morselli PL. Effect of amantadine on drug-induced parkisonism: relationship between plasma levels and effect. Br J Clin Pharmacol. 1976Abstract